Does ERTUGLIFLOZIN PIDOLATE Cause Product use issue? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Product use issue have been filed in association with ERTUGLIFLOZIN PIDOLATE (STEGLATRO). This represents 2.5% of all adverse event reports for ERTUGLIFLOZIN PIDOLATE.
17
Reports of Product use issue with ERTUGLIFLOZIN PIDOLATE
2.5%
of all ERTUGLIFLOZIN PIDOLATE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product use issue From ERTUGLIFLOZIN PIDOLATE?
Of the 17 reports, 1 (5.9%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTUGLIFLOZIN PIDOLATE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ERTUGLIFLOZIN PIDOLATE Cause?
Fungal infection (58)
Product dose omission issue (57)
Nausea (55)
No adverse event (53)
Urinary tract infection (52)
Diabetic ketoacidosis (34)
Dizziness (33)
Vomiting (31)
Blood glucose increased (30)
Product dose omission (27)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which ERTUGLIFLOZIN PIDOLATE Alternatives Have Lower Product use issue Risk?
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ETHYLSUCCINATE
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN LACTOBIONATE
ERTUGLIFLOZIN PIDOLATE vs ERYTHROPOIETIN
ERTUGLIFLOZIN PIDOLATE vs ESCHERICHIA COLI